Cefotetan
DrugCefotetan (as Disodium) 1 GM Injection before surgery
Other names: antibiotics group
NCT Number: NCT04726046
529 patients performed elective LCC at Chonbuk National University Hospital between April 2014 and August 2015. Total 509 patients were enrolled by inclusion criteria.
They were randomized studied by comparing with antibiotic group (n=249, AG, cefotetan 1g, 1 dose/prophylactic) and non-antibiotic group (n=260, NAG) by table of random numbers. The clinical variables were pre and post-operatively blood tests enclude WBC, ESR, CRP, body temperatures, symptoms and imaging of chest x-ray to evaluate the infections.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Phase 1
529 patients performed elective LCC at Chonbuk National University Hospital between April 2014 and August 2015. Total 509 patients were enrolled by inclusion criteria. They were randomized studied by comparing with antibiotic group (n=249, AG, cefotetan 1g, 1 dose/prophylactic) and non-antibiotic group (n=260, NAG) by table of random numbers. The clinical variables were pre and post-operatively blood tests enclude WBC, ESR, CRP, body temperatures, symptoms and imaging of chest x-ray to evaluate the infections.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
patients who have diagnosed -cholecystitis with / without GB stone, GB polyp
Exclusion criteria
Cefotetan (as Disodium) 1 GM Injection before surgery
Other names: antibiotics group
Time frame: 30days
surgical site infection
Chonbuk National University Hospital
Other
Prospective Randomized Control Study of Clinical Effectiveness of Prophylactic Antibiotics Therapy in Laparoscopic Cholecystectomy on Infection Rate
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06005701
Behavior, Bile Duct Diseases
Buraidah, Al-Qassim Region, Saudi Arabia
View Trial DetailsNCT06502028
Biliary Tract Diseases, Cholecystitis
Seoul, South Korea
View Trial DetailsNCT06198335
Biliary Tract Diseases, Cholecystitis
Bursa, Turkey (Türkiye)
View Trial DetailsNCT06981052
Biliary Tract Diseases, Cholecystitis
Worcester, Massachusetts, United States
View Trial Details